Clinical Trials Browser

Phase 3 × Recruiting × Uterine Cervical Neoplasms × Clear all

NCT05581121 2026-04-17

PAROLA

Phase 3 Recruiting

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT06459180 2026-04-17

TroFuse-020

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT07216703 2026-04-17

TroFuse-036

Phase 3 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT07418749 2026-04-06

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05078047 2025-06-05

MOIO

Phase 3 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06459687 2025-05-14

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT06641635 2025-03-18

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT06692166 2024-11-22

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT05764044 2024-07-30

AddChemo

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT06509724 2024-07-26

POHIM-P3

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT04422366 2024-06-07

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Phase 3 Recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms

NCT04895020 2024-04-17

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Phase 3 Recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05027776 2024-04-17

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Phase 3 Recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Papillomavirus Infections

NCT05173272 2023-12-27

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT03534713 2023-09-21

ONCOCOL01

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT04989647 2023-09-07

CERVANTES

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05735145 2023-02-21

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05277688 2022-09-16

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05367206 2022-05-10

N6C

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT04974346 2022-01-25

PAILACC

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT04733820 2021-02-02

Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery

Phase 3 Recruiting

Uterine Cervical Neoplasms